Related Experiment Video

Updated: Jun 27, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia

Courtney D Thornburg1, Natalia Dixon, Shelly Burgett

  • 1Duke Pediatric Sickle Cell Program and Division of Pediatric Hematology/Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA. courtney.thornburg@duke.edu

Pediatric Blood & Cancer
|December 9, 2008
PubMed

Insights

Hydroxyurea is well-tolerated in young children with sickle cell anemia (SCA). This treatment may help prevent chronic organ damage, showing promising results for managing SCA in pediatric patients.

Area of Science:

  • Pediatric Hematology
  • Sickle Cell Disease Management
  • Pharmacological Interventions

Background:

  • Hydroxyurea is known to improve laboratory markers and reduce acute complications in sickle cell anemia (SCA).
  • However, its long-term impact on organ function, particularly in young children, requires further investigation.

Purpose of the Study:

  • To evaluate the safety and efficacy of hydroxyurea in young children diagnosed with SCA.
  • To prospectively assess the effects of hydroxyurea on kidney and brain function in this pediatric population.

Main Methods:

  • A cohort of 14 young children with SCA (mean age 35 months) received hydroxyurea.
  • Treatment involved a mean maximum tolerated dose (MTD) of 28 mg/kg/day over a mean follow-up of 25 months.
  • Kidney function was assessed using DTPA clearance and Schwartz estimate, while brain function was evaluated with transcranial Doppler (TCD) and MRI/MRA.

Main Results:

  • Significant improvements in hemoglobin, MCV, and %HbF were observed, alongside decreases in reticulocytes and bilirubin.
  • No significant changes in glomerular filtration rate were detected.
  • Transcranial Doppler velocities showed significant decreases, and MRI/MRA confirmed no progression of brain ischemic lesions or vasculopathy.
  • Growth and neurocognitive scores remained stable, with improvements in family impact scores.

Conclusions:

  • Hydroxyurea at the MTD is well-tolerated by young children with SCA and their families.
  • These pilot findings suggest hydroxyurea may be effective in preventing chronic organ damage in this vulnerable group.
Abstract

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...